Burman, William J <br/><br/>
Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis.  [electronic resource] 

 -  American journal of respiratory and critical care medicine  Aug 2006 
 - 331-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1073-449X 
<br/><br/><label>Standard No.: </label>10.1164/rccm.200603-360OC  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Africa<br/>Antitubercular Agents--administration & dosage<br/>Aza Compounds--adverse effects<br/>Drug Administration Schedule<br/>Drug Therapy, Combination<br/>Ethambutol--adverse effects<br/>Female<br/>Fluoroquinolones<br/>Humans<br/>Male<br/>Moxifloxacin<br/>Mycobacterium tuberculosis--isolation & purification<br/>Quinolines--adverse effects<br/>Sputum--microbiology<br/>Tuberculosis, Pulmonary--drug therapy<br/>United States